Please sign in to follow a disease.
Phobic disorder
MONDO:0003699An anxiety disorder characterized by an intense, irrational fear of an object, activity, or situation. The individual seeks to avoid the object, activity, or situation. In adults, the individual recognizes that the fear is excessive or unreasonable.
Also known as: phobia
282 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsSub-types
Broader categories
-
Mental health sessions may boost vaccine uptake in latinx communities
Prevention TerminatedThis study tested whether adding vaccine discussions to routine behavioral health visits could reduce hesitancy and increase COVID-19 and flu shots among Latinx adults with mental illness. Clinicians used motivational interviewing and could offer a warm handoff to a nurse for vac…
Phase: NA • Sponsor: Boston College • Aim: Prevention
Last updated Jun 26, 2026 17:00 UTC
-
Brain stimulation may supercharge therapy for social anxiety
Symptom relief TerminatedThis study tested whether a mild electrical current applied to the forehead (tDCS) could make exposure therapy work better for people with social anxiety. Thirty-three adults with public speaking fears gave speeches in virtual reality while receiving either real or fake tDCS. The…
Phase: NA • Sponsor: University of Nevada, Reno • Aim: Symptom relief
Last updated Jun 27, 2026 12:05 UTC
-
Can a nasal spray calm social anxiety? trial ends early
Symptom relief TerminatedThis study tested a nasal spray called PH94B to see if it could quickly reduce anxiety in adults with social anxiety disorder during a public speaking task. About 228 participants were expected to take the spray or a placebo before speaking. The trial was terminated early, so res…
Phase: PHASE3 • Sponsor: VistaGen Therapeutics, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 07:59 UTC
-
Social anxiety nasal spray safety trial ends early
Symptom relief TerminatedThis study tested the safety of a nasal spray called PH94B for people with social anxiety disorder. Participants used the spray up to 4 times a day for up to 12 months when feeling anxious. The trial was terminated early, so we don't have full results on its safety or effectivene…
Phase: PHASE3 • Sponsor: VistaGen Therapeutics, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 07:55 UTC
-
Mental health study aims to uncover Long-Term heart risks
Knowledge-focused TerminatedThis study followed 167 adults with mental health issues like anxiety, depression, or sleep problems who visited their primary care doctor. Researchers used health conversations and a blood test to track lifestyle changes and heart disease risks over up to 20 years. The goal was …
Phase: NA • Sponsor: Region Skane • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:28 UTC